Correlation Between Phathom Pharmaceuticals and RAPT Therapeutics
Can any of the company-specific risk be diversified away by investing in both Phathom Pharmaceuticals and RAPT Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phathom Pharmaceuticals and RAPT Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phathom Pharmaceuticals and RAPT Therapeutics, you can compare the effects of market volatilities on Phathom Pharmaceuticals and RAPT Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phathom Pharmaceuticals with a short position of RAPT Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phathom Pharmaceuticals and RAPT Therapeutics.
Diversification Opportunities for Phathom Pharmaceuticals and RAPT Therapeutics
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Phathom and RAPT is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Phathom Pharmaceuticals and RAPT Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAPT Therapeutics and Phathom Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phathom Pharmaceuticals are associated (or correlated) with RAPT Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAPT Therapeutics has no effect on the direction of Phathom Pharmaceuticals i.e., Phathom Pharmaceuticals and RAPT Therapeutics go up and down completely randomly.
Pair Corralation between Phathom Pharmaceuticals and RAPT Therapeutics
Given the investment horizon of 90 days Phathom Pharmaceuticals is expected to generate 2.23 times less return on investment than RAPT Therapeutics. But when comparing it to its historical volatility, Phathom Pharmaceuticals is 1.44 times less risky than RAPT Therapeutics. It trades about 0.2 of its potential returns per unit of risk. RAPT Therapeutics is currently generating about 0.3 of returns per unit of risk over similar time horizon. If you would invest 1,265 in RAPT Therapeutics on July 24, 2025 and sell it today you would earn a total of 2,088 from holding RAPT Therapeutics or generate 165.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Phathom Pharmaceuticals vs. RAPT Therapeutics
Performance |
| Timeline |
| Phathom Pharmaceuticals |
| RAPT Therapeutics |
Phathom Pharmaceuticals and RAPT Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Phathom Pharmaceuticals and RAPT Therapeutics
The main advantage of trading using opposite Phathom Pharmaceuticals and RAPT Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phathom Pharmaceuticals position performs unexpectedly, RAPT Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAPT Therapeutics will offset losses from the drop in RAPT Therapeutics' long position.The idea behind Phathom Pharmaceuticals and RAPT Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| RAPT Therapeutics vs. DBV Technologies | RAPT Therapeutics vs. Autolus Therapeutics | RAPT Therapeutics vs. Rocket Pharmaceuticals | RAPT Therapeutics vs. MBX Biosciences, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |